New Twitter Mentions for David Henry

@davidhenrymd

Mentions: 21 - Followers: 2,137

Practicing MD Hematologist Oncologist Vice Chair Dept of Medicine Pennsylvania Hospital Blood&Cancer host Research-supportive care @MDedgeTweets @MDedgeHemeOnc

@davidhenrymd was mentioned in Changing perspectives: Dr. Michael Weiner recounts his experiences as an oncologist who became a cancer patient and then a caregiver

Blood & Cancer

@davidhenrymd was mentioned in Toward more personalized treatment in prostate cancer: The CCR score predicts metastasis and guides treatment decisions after radiation

Blood & Cancer

@davidhenrymd was mentioned in Thrombosis and thrombocytopenia caused by COVID-19 vaccines: How to identify and treat VITT, VIPIT, or TTS

Blood & Cancer

@davidhenrymd was mentioned in Gene therapies in hemophilia with Dr. Glenn Pierce

Blood & Cancer

@davidhenrymd was mentioned in Biosimilars with Dr. Gary Lyman

Blood & Cancer

@davidhenrymd was mentioned in Optimizing CAR T-cell therapies in lymphoma: Improving response, fighting cytokine release syndrome, and identifying mechanisms of resistance

Blood & Cancer

@davidhenrymd was mentioned in FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies

Blood & Cancer

@davidhenrymd was mentioned in Unpacking von Willebrand disease guidelines: Dr. Paula James talks diagnosis and pre-procedure prophylaxis

Blood & Cancer

@davidhenrymd was mentioned in COVID-19 vaccination in cancer patients: Who should be vaccinated and when?

Blood & Cancer

@davidhenrymd was mentioned in FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs

Blood & Cancer

@davidhenrymd was mentioned in NCI-MATCH trial reveals actionable mutations and matches cancer patients to targeted therapies

Blood & Cancer

@davidhenrymd was mentioned in Barriers to clinical trial enrollment for patients with gynecologic cancers: Why patients don’t participate and how to improve enrollment

Blood & Cancer

@davidhenrymd was mentioned in Convalescent plasma for COVID-19, race linked to cancer-associated thrombosis risk, iron deficiency common in pregnancy, and more from ‘Best of ASH’

Blood & Cancer

@davidhenrymd was mentioned in Highlights from SABCS 2020: New data on CDK4/6 inhibitors, omitting chemotherapy and radiotherapy, underreporting toxicity, and predicting outcomes in breast cancer

Blood & Cancer

@davidhenrymd was mentioned in Best of Blood & Cancer 2020

Blood & Cancer

@davidhenrymd was mentioned in How I treat NSCLC in the era of checkpoint inhibitors and the COVID-19 pandemic

Blood & Cancer

@davidhenrymd was mentioned in Post-HSCT care at home: Can maintaining the patient’s microbiome prevent GVHD, improve other outcomes, decrease costs, and reduce the risk of COVID-19?

Blood & Cancer

@davidhenrymd was mentioned in How I treat NSCLC in the era of PD-L1 inhibitors and the COVID-19 pandemic

Blood & Cancer

@davidhenrymd was mentioned in ESMO 2020: Late-breaking and practice-changing studies on COVID-19 and breast, lung, gastrointestinal, and other cancers

Blood & Cancer

@davidhenrymd was mentioned in COVID-19: ‘The world has changed’

Blood & Cancer

@davidhenrymd was mentioned in 2019 drug approvals in hematology-oncology

Blood & Cancer

Filter by Podcast

Blood & Cancer 21